Doctors expected that cannabis use would pose a risk for heart failure patients, but found that the opposite was true. They also found that cannabis users were less likely to die in the hospital.
A research team has made the discovery that cannabis may have benefits for those suffering from heart problems. At a recent meeting of the American Heart Association’s Scientific Sessions, Dr. Oluwole Adegbala, medical resident at Englewood Hospital and Medical Center in New Jersey, presented the findings of an unpublished study on the link between cannabis use and heart failure. Previous research has suggested links between cannabis use and heart problems, and the research team fully expected to find evidence supporting claims that cannabis users were at greater risk of heart-related health problems.
Instead, the team was “surprised” to find that cannabis users were less likely to experience atrial fibrillation (A-fib), an irregularity of the heartbeat that can worsen the symptoms of heart failure, compared to non-users. Dr. Adegbala and his colleagues analyzed a database of over 6 million patients suffering from heart failure who were admitted to the hospital between 2007 and 2014. Around 23,000 of these patients reportedly used cannabis but were not considered dependent on the drug, and another 1,200 patients were considered dependent cannabis users, LiveScience reports.
The research team found that the non-dependent cannabis users were 18% less likely than non-users to experience A-fib, and were also 46% less likely to die in the hospital. The dependent cannabis users were 31% less likely to develop A-fib and 58% less likely to die in the hospital than non-users. Researchers adjusted their data to account for age, socioeconomic status, and use of other drugs, and discovered that their findings were still solid.
Dr. Adegbala told LiveScience that his team was not able to identify the exact reasons why cannabis might decrease the risk of A-fib or mortality for heart failure patients. Previous research in animals has found that high blood pressure and atherosclerosis, two risk factors for A-fib, can be reduced by activating cannabinoid receptors. Dr. Adegbala also noted that cannabidiol can reduce inflammation, which is another risk factor for A-fib. Despite their positive findings, the research team does not recommend that heart failure patients begin using cannabis as a treatment until further research can be conducted to support or refute the findings of this study.
( NASDAQOTH:MJNA ). While GW Pharmaceuticals currently holds the title of being the largest pot stock by a mile, Medical Marijuana, Inc. holds the distinction of being the first publicly listed marijuana stock. Unlike most marijuana stocks that tend to focus on developing a handful of products or a small portfolio of cannabinoid-based drugs, Medical Marijuana, Inc. is a holding company that’s invested in more than a half-dozen cannabidiol (CBD)-product companies for the pharmaceutical, nutraceutical, cosmeceutical, or industrial hemp industries. The company’s eight listed subsidiaries and investments include: HempMeds, which offers marketing and sales of CBD-based products in the U.S.; Kannaway, which specializes in hemp-based botanical products; KannaLife Sciences, which is a cannabinoid-based drug developer; Axim Biotechnologies, which is also a developer of cannabinoid-based medicines; MPS International, a security consultation service for the weed industry; Wellness Managed Services, which provides support services to the pot industry. The most obvious reason marijuana stock investors are Green Rush likely excited about a company like Medical Marijuana, Inc. is its portfolio diversity. Its complete ownership of HempMeds and investments in KannaLife Sciences and Axim Biotechnologies gives the company access to retail CBD product sales, as well as the opportunity to earn significant investment rewards if Axim’s and KannaLife’s cannabinoid-based products succeed in clinical trials.
And only those companies that are well capitalized will be able to successfully compete in 2018. Truth is, I won’t touch a cannabis company that doesn’t have a war chest of capital going into 2018. The market is getting too competitive, and those that are not well capitalized will be out of business by the end of next year. Market share is also incredibly important. This is where Canada really shines, as the biggest players in this market also have exposure in other countries, including the U.S., Germany, Colombia, Israel, and Australia. Medical marijuana And, of course, management is key. In fact, I often say that it’s management in which I invest, not companies. Similar to the way we’ve seen this factor play a role in the success of stocks like Tesla (NASDAQ: TSLA), Amazon (NASDAQ: AMZN), and Apple (NASDAQ: AAPL), the same holds true of the cannabis space. As an expert in this field, I’ve come to know and respect the most successful management teams in this space.
marijuana-related activities are expected to: Describe the nature of the public company’s involvement in the U.S. marijuana industry and include the disclosures indicated based on the nature of such involvement as either direct, indirect or ancillary (as discussed below); Explain that marijuana remains illegal under U.S. federal law and that the approach to enforcement by the U.S. federal government is subject to change, as well as a discussion of resultant risks of such change including the potential for adverse enforcement action; State whether and how the public company’s marijuana-related activities are conducted in a manner consistent with any U.S. federal enforcement priorities; and Given the illegality of marijuana under U.S. federal law, discuss the public company’s ability to access both public and private capital markets and indicate what financing options are available to support continuing operations. For public companies directly Green Rush engaged in the cultivation or distribution of marijuana in the U.S. in accordance with a state license, the following disclosure is required: An outline of the regulations for the U.S. state(s) in which the public company operates and confirm how the public company complies with applicable licensing requirements and the applicable regulatory framework; A discussion of the public company’s program for monitoring compliance with U.S. state law on an ongoing basis and its internal compliance mechanisms; and Disclosure of any material non-compliance, as well as material citations or notices of violation. For public companies with indirect involvement in cultivation or distribution of marijuana by way of a non-controlling investment in an entity who is directly involved in the U.S.
The credit rating agency estimates state and local taxes on marijuana, which will become Marijuana Stocks legal in California on Jan. 1., could be as high as 45 percent in some cases. It would trail only Washington state, which levies a 50 percent tax on marijuana. “The existing black market for cannabis may prove a formidable competitor to legal markets if new taxes lead to higher prices than available from illicit sources,” the report says. Recreational marijuana will be taxed on both the state and local level, contributing to the potential for high rates. California will impose a 15 percent excise tax, as well as cultivation taxes. Municipalities will also levy sales tax and a business tax, which could be anywhere from 1 to 20 percent, on gross receipts. Business taxes on recreational marijuana have been approved by voters in 61 California cities and counties, according to the report. These high tax rates have the potential to drive customers toward the black market. The state is the nation’s epicenter of marijuana growing and has long provided black market pot. The report states that Colorado, Oregon and Washington all reduced tax rates after the commencement of legalization to shift customers back toward the legal market. California will implement a statewide framework for marijuana legalization, but each municipality must decide whether it wants to house marijuana businesses and, if so, map out its own regulations and tax structure.
New Hampshire Lawmakers on Marijuana Panel Begin Examination of Legalization The commission tasked with exploring legalization in the state will issue its final report next November. A commission tasked with exploring marijuana legalization in New Hampshire held its first meeting Tuesday, setting off a yearlong examination process ahead of its final report next November. Created by House Bill 215, the commission is charged with looking at what might happen if the state legalized marijuana, regulating and taxing it like alcohol, along the model of other states. STATE BY STATE: New Hampshire Cannabis News The goal is broad. Among the topics to be considered, according to the commission, are how legalization might affect the opioid crisis, crime rates, children’s health, DUI accidents, taxation policies and New Hampshire’s brand. “To me, in simple form, Green Rush I think it’s our job to identify the good, the bad and the ugly of legalization,” Rep. Patrick Abrami, the commission’s chairman, said at the meeting Tuesday. The commission will reach out to states that have already undertaken the effort, such as Colorado, which implemented legalization in 2014, and Massachusetts, which will roll out its legalization effort next summer. Members will try to set up video conferences with state officials over Skype, said Abrami, a Stratham Republican.
The number of farms in Mendocino County, where the illicit market thrives, is unknown. Both the California Cannabis Industry Association and the California Growers Association reported ” several dozen ” members that lost their farms in the blazes. It’s too soon to say what percent of grows in California were affected by the fires, though it appears to be a minority. Smoke also blanketed huge swaths of Northern California last week, which presents a more widespread concern for the marijuana industry, according to Nick DiNicola, whose company, DiNicola Insurance Services, brokers insurance for companies in the cannabis space. “A lot of the farms weren’t destroyed but may Medical marijuana stocks not be able to sell their product because of all the pollution that came down from the fires,” DiNicola told Business Insider. Smoke-exposed crops are more vulnerable to disease , which could lead to unhealthy levels of mold, mildew, and fungus. The marijuana might also smell like fire, which causes it to lose value if it’s meant to smell like “lemon haze” or “blueberry kush,” according to the San Francisco Chronicle . Flames surround a marijuana plant as a wildfire burns near Oroville, California, on Saturday, July 8, 2017. Noah Berger/AP Still, the fires reached only a small section of the Emerald Triangle, which also includes Humboldt County and Trinity County. Local dispensaries that source their inventory from the counties affected by the fires are more likely to experience higher prices.
Among other responsibilities, Mr. Vleeming was in charge of the division running the corporation’s mission critical IT systems, general IT asset management, as well as development of the corporation’s strategic technology vision to drive competitive differentiation. Prior to Capital Power, Mr. Vleeming was Manager of Systems Development at EPCOR, one of Canada’s top providers of energy and energy-related services and products in Alberta, Ontario, and the United States. Mr Vleeming sits on the Board of Directors of a number of not-for-profit and charitable organizations, including Cybera, which is responsible for overseeing the development of Alberta’s cyber infrastructure, and The Rainbow Society of Alberta, a registered charity dedicated to fulfilling wishes of Alberta children with chronic or life threatening illnesses. Mr. Vleeming holds an Executive MBA from the University of Athabasca, and a Computer Systems Technology Honours Diploma from the Northern Alberta Institute of Technology (NAIT). The newly created position of CIO reflects the degree to which leadership in technology and innovation is part of our DNA, as well as central to our global expansion strategy. With his exceptional track record of identifying technological opportunities and executing technology-driven strategies, we believe Darryl is the right person to help us scale up Aurora’s e-commerce platform, establish systems to manage the vast amount of data we generate, and ensure tight alignment across our domestic and international operations. We are very pleased to have attracted a leader of his calibre, and look forward to his contributions to driving accelerated growth.
To read more visit marijuana href=’https://www.newcannabisventures.com/aurora-cannabis-appoints-darryl-vleeming-chief-information-officer/’ rel=’nofollow’>https://www.newcannabisventures.com/aurora-cannabis-appoints-darryl-vleeming-chief-information-officer/
Chart source: thinkorswim® by TD Ameritrade . Data source: Standard & Poor’s. Not a recommendation. For illustrative purposes only. Past performance does not guarantee future results. Eight states and Washington D.C. have legalized the recreational use of marijuana, and 44 states have laws governing medicinal use. Laws vary from state to state, which adds complexities that can result in companies or individuals violating state production and distribution laws. An even greater source of uncertainty for companies is that all these activities are illegal under federal law because marijuana is still a Schedule I substance under the Controlled Substances Act. The U.S. Drug Enforcement Administration defines Schedule I substances as “drugs with no currently accepted medical use and a high potential for abuse.” How are these companies getting away with it then?